• Profile
Close

Urinary biomarkers of tubular damage are associated with mortality but not cardiovascular risk among Systolic Blood Pressure Intervention Trial participants with chronic kidney disease

American Journal of Nephrology Apr 05, 2019

Jotwani VK, et al. - Researchers investigated if a higher risk of cardiovascular disease (CVD) and mortality could be seen in chronic kidney disease (CKD) patients relative to urinary biomarkers of tubular injury, inflammation, and repair. Among 2,377 participants of the Systolic Blood Pressure Intervention Trial with an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, measurements of urinary concentrations of interleukin-18 (IL-18), kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein-1, and chitinase-3-like protein-1 (YKL-40) were obtained at baseline. They assessed biomarker links with CVD events and all-cause mortality by using Cox proportional hazards models. A higher risk of mortality, but not CVD, was found in relation to higher urinary IL-18 and YKL-40 among hypertensive trial participants with CKD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay